SOURCE: Enzyme Environmental Solutions, Inc.

Enzyme Environmental Solutions, Inc.

February 26, 2009 13:58 ET

Enzyme Environmental Solutions Estimates in Excess of 100M for 2009

Outlook Exceeds Management Expectations Based on Product Order and Licensing Fees

FORT WAYNE, IN--(Marketwire - February 26, 2009) - Enzyme Environmental Solutions Inc. (PINKSHEETS: EESO) has set the stage for a breakthrough year by harvesting technology and vendors in medical, commercial/industrial and retail product formula lines.

"It's been a tremendous year and we're not even finished with first quarter. In addition to the recent coup secured with our exclusive retail partner, we've been underway on innovative solutions for medical and industrial sectors in addition to the successes we've had with Pit Solution and GC 2000 technologies," states Jared Hochstedler, CEO and President of the progressive green biotech company. "We have reviewed existing licensing agreements and product orders and have been conservative with received Letters of Intent and projected manufacturing orders and biotech licensing requests from several commercial vendors in sectors anywhere among the steel industry, medical fields and water treatment, among others and have estimated, moderately, projected gross sales are in excess of $136,000,000.00 ($136M) by end of 4th quarter, 2009. This does not include pending prospective contracts with Southeast Asia and the multitude of formula applications therein."

Hochstedler continues, "We have worked diligently to secure alliances worldwide as part of an overall global strategy, introducing formulas and other biotechnology IP and took a risk in doing so; but it wasn't for a lack of vision. This was a large move I felt strongly about pursuing based on several vendor inquiries. The traditional model of simply getting products onto store shelves wasn't big enough for our overall mission: 'Cleaner world. Safer planet.'... It was an overall deliberate shift in market focus and distribution avenues on the retail side... and aggressively pursuing government agencies and entertaining solution requests from vendors internationally."

It's certainly paid off for EESO. The company recently released financials for Q3 and Q4 of 2008 on and was upgraded to a 'limited information' company. EESO is currently in the process of fulfilling Pink OTC requirements toward 'current information' status as part of its promise to increase transparency and overall investor confidence as it paves the way for continued success and growth in the Green Biotech market internationally.

The company looks forward to sharing news of this forthcoming progress at tomorrow's Open House event at their Fort Wayne, Indiana offices.

Safe Harbor: This release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approvals for anticipated actions.

Contact Information